Light Therapy in End Stage Kidney Disease

{ "Light Therapy for Fatigue in End-Stage Kidney Disease", "This study is testing if light therapy can help reduce fatigue in people with end-stage kidney disease who are receiving hemodialysis (a treatment that filters your blood). Participants will use special glasses, either the \"Re-timer\" device which provides bright light, or identical-looking glasses that provide dim light. You would wear these glasses for one hour during your dialysis sessions, three times a week, for four weeks. The main goal is to see if bright light therapy makes a difference in how tired you feel, measured by a Fatigue Severity Scale. To join, you need to be at least 18 years old, have end-stage kidney disease requiring hemodialysis three times a week for at least one month, and have a Fatigue Severity Scale score greater than 9. The study plans to enroll 60 participants, but its current status is unclear.", "design": "This is a randomized controlled trial with two groups (bright light and dim light) and plans to enroll 60 participants.", "commitments": "You would use a light device for 60 minutes during your dialysis sessions, three times a week, for four weeks.", "compensation": "Not stated in the trial record.", "follow_up": "Fatigue severity will be measured at 4 weeks after starting the treatment.", }

Study design
Not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06310161

Light Therapy in End Stage Kidney Disease

Active, Not Recruiting
NAAges 18+InterventionalTreatment
University of Pennsylvania
~60 participants
Updated 2026-08-21 on ClinicalTrials.gov
What's tested:Bright lightDim Light

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Fatigue Severity Scale
Measured over 4 weeks
End Stage Renal Disease
1 sites across 1 states
Pennsylvania1
  • Lea Ann Matura, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Fatigue Severity Scale4 weeks

    Measures how bad or severe a person's fatigue is. Score range from 9-63; higher scores indicate increased fatigue.